Identification and characterization of genes associated with human hepatocellular carcinogenesis.

Eight cDNAs encoding galectin 4 (Gal-4), UGT2B4 (UDP-glucuronosyltransferase), ribosomal phosphoprotein P0 (rpP0), dek, insulin-like growth factor binding protein (IGFBP) 1, vitronectin, retinoic acid-induced gene E (RIG-E), and CYP3A4 (cytochrome P450 nifedipine oxidase) were identified as differentially expressed genes between human hepatocellular carcinoma (HCC) and matched nontumorous liver tissues. Higher levels of UGT2B4, rpP0, dek, vitronectin, Gal-4, and IGFBP-1 mRNAs combined with a lower level of RIG-E mRNA were observed in at least four of five primary HCCs compared to matched nontumorous liver tissues. Furthermore, a pathological study suggested that the levels of UGT2B4, rpP0, dek, and vitronectin increased and the level of RIG-E decreased with the histological grading. On the other hand, the expression of CYP3A4 mRNA and CYP3A7 (P-450 Fla) mRNA, a transcript found in the fetus and highly homologous to CYP3A4, was higher in all nontumorous liver and some of the carcinoma tissues from five HCC patients, whereas it was significantly lower in normal liver tissues from two non-HCC patients. The examination using HCC cell lines HuH-7 and HepG2 under different growth conditions suggested that the expression of dek mRNA was growth-associated. In contrast, the expression of Gal-4, UGT2B4, IGFBP-1, and RIG-E mRNAs was regulated in a cell density-dependent manner: the levels of Gal-4, UGT2B4, and IGFBP-1 were undetectably low, whereas the level of RIG-E was high in rapidly proliferating, subconfluent HCC cells in 10% serum; however, the expression levels were reversed in dense, overcrowded cultures. In addition, IGFBP-1 and Gal-4 mRNAs were also induced by reducing the serum concentration to 0.1%. We also demonstrated that sodium butyrate, an inducer of differentiation, up-regulated and down-regulated RIG-E and dek mRNAs, respectively, in a dose-dependent manner in HuH-7 cells, supporting, in part, our pathological observation. In summary, therefore, high expression of Gal-4, UGT2B4, rpP0, dek, IGFBP-1, and vitronectin, together with low expression of RIG-E, was correlated with the malignant potential of HCC. CYP3A4 and CYP3A7 could be induced in HCC-bearing livers. These transcripts are differentially regulated depending on cell-cell contact, serum growth factors, growth and differentiation status, and/or other mechanisms in premalignant and malignant liver cells.

[1]  C. Li,et al.  Differentiation and antiproliferation effects of retinoic acid receptor beta in hepatoma cells. , 1998, Cancer letters.

[2]  S. Pastoreková,et al.  A novel quasi-viral agent, MaTu, is a two-component system. , 1992, Virology.

[3]  D. Sarma,et al.  Hepatocarcinogenesis: a dynamic cellular perspective. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[4]  M. Katsuki,et al.  In vivo detection of mutations induced by aflatoxin B1 using human CYP3A7/HITEC hybrid mice. , 1998, Biochemical and biophysical research communications.

[5]  T. Kamataki,et al.  Fetus-specific CYP3A7 and adult-specific CYP3A4 expressed in Chinese hamster CHL cells have similar capacity to activate carcinogenic mycotoxins. , 1995, Cancer research.

[6]  C. S. Lee,et al.  Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell lines. , 1991, Oncogene.

[7]  D. Hum,et al.  Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene. , 1999, Pharmacogenetics.

[8]  N. Sonenberg,et al.  Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap , 1990, Nature.

[9]  J. Dagorn,et al.  Cloning and expression of the mRNA of human galectin-4, an S-type lectin down-regulated in colorectal cancer. , 1997, European journal of biochemistry.

[10]  C. Chang,et al.  Evidence of autocrine regulation in human hepatoma cell lines. , 1988, Biochemical and biophysical research communications.

[11]  P. De Giuli,et al.  Galectin-3 is a presurgical marker of human thyroid carcinoma. , 1998, Cancer research.

[12]  M. Katsuki,et al.  In vivo activation of aflatoxin B1 in C57BL/6N mice carrying a human fetus-specific CYP3A7 gene. , 1997, Cancer research.

[13]  J. Miners,et al.  cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily. , 1993, Biochemical and biophysical research communications.

[14]  T. Kamataki,et al.  Molecular cloning and sequence analysis of cDNA containing the entire coding region for human fetal liver cytochrome P-450. , 1989, Journal of biochemistry.

[15]  M. Loda,et al.  Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction. , 1991, Oncogene.

[16]  Y. Nakamura,et al.  Genomic structure and chromosomal localization of GML (GPI-anchored molecule-like protein), a gene induced by p53. , 1997, Genomics.

[17]  N. Kondoh,et al.  Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation. , 1992, Cancer research.

[18]  D. Powell,et al.  Insulin-like growth factor (IGF) suppression of IGFBP-1 production: evidence for mediation by the type I IGF receptor , 1993, Regulatory Peptides.

[19]  M. Manns,et al.  Differential down-regulation of the UDP-glucuronosyltransferase 1A locus is an early event in human liver and biliary cancer. , 1997, Cancer research.

[20]  N. Hayashi,et al.  Expression of the c‐met protooncogene in human hepatocellular carcinoma , 1994, Hepatology.

[21]  Yusuke Nakamura.  ATM: the p53 booster , 1998, Nature Medicine.

[22]  K. Koike,et al.  Activated N-ras gene was found in human hepatoma tissue but only in a small fraction of the tumor cells. , 1989, Oncogene.

[23]  D. Clemmons,et al.  Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.

[24]  L. Giudice,et al.  Insulin-like Growth Factor Binding Protein-1: Recent Findings and New Directions , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[25]  Y. Wan,et al.  Retinoic acid differentially regulates retinoic acid receptor-mediated pathways in the Hep3B cell line. , 1998, Experimental cell research.

[26]  K. Mitsumori,et al.  Point mutations of the c-H-ras gene in spontaneous liver tumors of transgenic mice carrying the human c-H-ras gene. , 1998, Toxicologic pathology.

[27]  K. Mitsumori,et al.  Point Mutations of the c-H-ras Gene in Spontaneous Liver Tumors of Transgenic Mice Carrying the Human c-H-ras Gene , 1998 .

[28]  R. Bresalier,et al.  Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3. , 1998, Gastroenterology.

[29]  F. Tronche,et al.  Liver-specific expression of human insulin-like growth factor binding protein 1: functional role of transcription factor HNF1 in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  P. Cerutti,et al.  Mutagenesis of the H-ras protooncogene and the p53 tumor suppressor gene. , 1994, Cancer research.

[31]  R. Lotan,et al.  Expression of galectins in head and neck squamous cell carcinoma , 1996, Head & neck.

[32]  K. Mafune,et al.  Increased expression of human ribosomal phosphoprotein P0 messenger RNA in hepatocellular carcinoma and colon carcinoma. , 1992, Cancer research.

[33]  R. Lotan,et al.  Transformation‐related changes in the expression of endogenous cell lectins , 1987, International journal of cancer.

[34]  H. Kawasaki,et al.  Overexpression of a beta-galactoside binding protein causes transformation of BALB3T3 fibroblast cells. , 1991, Biochemical and biophysical research communications.

[35]  P. Hofschneider,et al.  The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. , 1996, Virology.

[36]  E. H. Cohen,et al.  Characterization and mapping to human chromosome 8q24.3 of Ly-6-related gene 9804 encoding an apparent homologue of mouse TSA-1. , 1998, Journal of immunology.

[37]  R. Lubet,et al.  Two human liver cDNAs encode UDP-glucuronosyltransferases with 2 log differences in activity toward parallel substrates including hyodeoxycholic acid and certain estrogen derivatives. , 1992, Biochemistry.

[38]  Cytochrome P450 3A4 mediated metabolism of 2,4-dichlorophenol. , 1997, Chemosphere.

[39]  T. Cresteil,et al.  Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. , 1997, European journal of biochemistry.

[40]  S. Thorgeirsson,et al.  Analysis of c-myc expression in a human hepatoma cell line. , 1987, Cancer research.

[41]  N. Ogata,et al.  Point mutation, allelic loss and increased methylation of c‐Ha‐Ras gene in human hepatocellular carcinoma , 1991, Hepatology.

[42]  C. Chou,et al.  Transcripts of the insulin-like growth factors I and II in human hepatoma. , 1989, Cancer research.

[43]  K. Jaskiewicz,et al.  Differential expression of extracellular matrix proteins and integrins in hepatocellular carcinoma and chronic liver disease. , 1993, Anticancer research.

[44]  C. Bréchot,et al.  Structure and expression of the cyclin A gene in human primary liver cancer. Correlation with flow cytometric parameters. , 1995, Journal of hepatology.

[45]  T. Gansler,et al.  c-myc amplification in hepatocellular carcinoma predicts unfavorable prognosis. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[46]  R. Traut,et al.  Monoclonal antibodies against acidic phosphoproteins P0, P1, and P2 of eukaryotic ribosomes as functional probes. , 1990, The Journal of biological chemistry.

[47]  M. Fornerod,et al.  The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA , 1992, Molecular and cellular biology.

[48]  E. Ruoslahti,et al.  Detachment of cells from culture substrate by soluble fibronectin peptides , 1985, The Journal of cell biology.

[49]  E. Morgan.  Regulation of cytochromes P450 during inflammation and infection. , 1997, Drug metabolism reviews.

[50]  G. Fu,et al.  RIG-E, a human homolog of the murine Ly-6 family, is induced by retinoic acid during the differentiation of acute promyelocytic leukemia cell. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[51]  F. Gonzalez,et al.  Constitutive expression of hepatic cytochrome P450 genes , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[52]  D. Spandidos,et al.  Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues. , 1989, Anticancer research.

[53]  T. Shimada,et al.  Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[54]  M. Lai,et al.  Activation of protooncogene c-jun by the X protein of hepatitis B virus. , 1993, Virology.

[55]  H. Hsu,et al.  Amplification of the c-myc gene in human hepatocellular carcinoma: biologic significance. , 1993, Journal of the Formosan Medical Association = Taiwan yi zhi.

[56]  M. Krishna,et al.  Activation of ras oncogenes during hepatocarcinogenesis induced by N-nitrosodiethylamine: possible involvement of PKC and GAP. , 1996, Cancer letters.

[57]  A. Columbano,et al.  Liver regeneration versus direct hyperplasia , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  M. Meyn,et al.  Expression cloning of multiple human cDNAs that complement the phenotypic defects of ataxia-telangiectasia group D fibroblasts. , 1993, American journal of human genetics.

[59]  S. Nagataki,et al.  Reciprocal regulation of α-fetoprotein and albumin gene expression by butyrate in human hepatoma cells , 1994 .

[60]  C. Harris,et al.  Aflatoxin B1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines. , 1997, Carcinogenesis.

[61]  J. Chiu,et al.  The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors. , 1990, Oncogene.

[62]  H. Inohara,et al.  Galectin-3 stimulates cell proliferation. , 1998, Experimental cell research.

[63]  J. Schuetz,et al.  Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. , 1994, Pharmacogenetics.

[64]  D. Markovitz,et al.  DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[65]  J. Bruix,et al.  c‐met mRNA overexpression in human hepatocellular carcinoma , 1994, Hepatology.

[66]  T. Kurata,et al.  Hepatitis C and B virus infections in hepatocellular carcinoma: Analysis of direct detection of viral genome in paraffin embedded tissues , 1996, Cancer.